Weijie Ma

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 13

Top Topics

Tyrosine Kinase

Fluorescence Imaging

Brain Metastases

Top Venues

Molecular cancer therapeutics

International journal of molecular sciences

American journal of clinical pathology

This page only lists publications with an associated author ORCID identifier.

Publications

Weijie Ma, Sixi Wei, Qianping Li, Jie-Zeng Yu, Wenwu Xiao, Chihong Heidi Zhou, Ken Y Yoneda, Amir A Zeki, Tianhong Li
Simvastatin Overcomes Resistance to Tyrosine Kinase Inhibitors in Patient-derived, Oncogene-driven Lung Adenocarcinoma Models. Molecular cancer therapeutics 23 (5) (2024)
Weijie Ma, Sixi Wei, Qianping Li, Jie-Zeng Yu, Wenwu Xiao, Chihong Heidi Zhou, Ken Y Yoneda, Amir A Zeki, Tianhong Li
Simvastatin Overcomes Resistance to Tyrosine Kinase Inhibitors in Patient-derived, Oncogene-driven Lung Adenocarcinoma Models. Molecular cancer therapeutics 23 (5) (2024)
Tianhong Li, Weijie Ma, Ebaa Al-Obeidi
Evolving Precision First-Line Systemic Treatment for Patients with Unresectable Non-Small Cell Lung Cancer. Cancers 16 (13) (2024)
Tianhong Li, Weijie Ma, Ebaa Al-Obeidi
Evolving Precision First-Line Systemic Treatment for Patients with Unresectable Non-Small Cell Lung Cancer. Cancers 16 (13) (2024)
Weijie Ma, Sixi Wei, Qianping Li, Jie-Zeng Yu, Wenwu Xiao, Chihong Heidi Zhou, Ken Y Yoneda, Amir A Zeki, Tianhong Li
Simvastatin overcomes resistance to tyrosine kinase inhibitors in patient-derived, oncogene-driven lung adenocarcinoma models. Molecular cancer therapeutics (2024)
Weijie Ma, Sixi Wei, Qianping Li, Jie-Zeng Yu, Wenwu Xiao, Chihong Heidi Zhou, Ken Y Yoneda, Amir A Zeki, Tianhong Li
Simvastatin Overcomes Resistance to Tyrosine Kinase Inhibitors in Patient-derived, Oncogene-driven Lung Adenocarcinoma Models. Molecular cancer therapeutics 23 (5) (2024)
Weijie Ma, Dana L Wright, Ourania Parra, Nidhi D Shah, Candice C Black, Michael L Baker, Wahab A Khan
Identification of novel TTN gene variant in a patient exhibiting severe dilated cardiomyopathy co-occurring with acute fibrinoid organizing pneumonia. American journal of clinical pathology (2024)
Jiexi Wen, Jie-Zeng Yu, Catherine Liu, A Aziz O Ould Ismail, Weijie Ma
Exploring the Molecular Tumor Microenvironment and Translational Biomarkers in Brain Metastases of Non-Small-Cell Lung Cancer. International journal of molecular sciences 25 (4) (2024)
Weijie Ma, Sixi Wei, Qianping Li, Jie-Zeng Yu, Wenwu Xiao, Chihong Heidi Zhou, Ken Y Yoneda, Amir A Zeki, Tianhong Li
Simvastatin Overcomes Resistance to Tyrosine Kinase Inhibitors in Patient-derived, Oncogene-driven Lung Adenocarcinoma Models. Molecular cancer therapeutics 23 (5) (2024)
Jiexi Wen, Jie-Zeng Yu, Catherine Liu, A Aziz O Ould Ismail, Weijie Ma
Exploring the Molecular Tumor Microenvironment and Translational Biomarkers in Brain Metastases of Non-Small-Cell Lung Cancer. International journal of molecular sciences 25 (4) (2024)
Jiexi Wen, Jie-Zeng Yu, Catherine Liu, A Aziz O Ould Ismail, Weijie Ma
Exploring the Molecular Tumor Microenvironment and Translational Biomarkers in Brain Metastases of Non-Small-Cell Lung Cancer. International journal of molecular sciences 25 (4) (2024)
Weijie Ma, Jie Zeng, Dennis J Montoya, Kyra Toomey, Chihong Zhou, Shuai Chen, Dingning Liu, Michael Babich, James A Radosevich, Tianhong Li
Labyrinthin Expression Is Associated with Poor Prognosis in Patients with Non-Small-Cell Lung Cancer. Cancers 15 (3) (2023)
Weijie Ma, Jie Zeng, Dennis J Montoya, Kyra Toomey, Chihong Zhou, Shuai Chen, Dingning Liu, Michael Babich, James A Radosevich, Tianhong Li
Labyrinthin Expression Is Associated with Poor Prognosis in Patients with Non-Small-Cell Lung Cancer. Cancers 15 (3) (2023)